APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrine Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Endocrine Testing Service Market Outlook and Growth Opportunities 2026

1 January 2026205 pages

Choose your research edition.

Industry ResearchEndocrine Testing Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrine Testing Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Endocrine Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrine Testing Service Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrine Testing Service Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Endocrine Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Endocrine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Endocrine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endocrine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Endocrine Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Endocrine Testing Service market include Hoffmann-La Roche Ltd., Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A. and Immunodiagnostic Systems, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Endocrine Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Endocrine Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Endocrine Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Endocrine Testing Service market.

Endocrine Testing Service Segment by Company

Hoffmann-La Roche Ltd.

Abbott Laboratories

Agilent Technologies

BioMerieux S.A.

Bio-Rad Laboratories, Inc.

Siemens Healthineers

Danaher Corporation

DiaSorin S.p.A.

Immunodiagnostic Systems

Laboratory Corporation of America Holdings

Fujirebio, Inc.

Thermo Fisher Scientific Inc.

Quest Diagnostics

Sysmex Corporation

MP Biomedicals

Ortho Clinical Diagnostics

Meridian Life Science, Inc.

Endocrine Testing Service Segment by Type

Prolactin Testing

Progesterone Testing

Testosterone Testing

Endocrine Testing Service Segment by Application

Hospitals

Clinics

Endocrine Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Endocrine Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Endocrine Testing Service key companies, revenue, market share, and recent developments.

3. To split the Endocrine Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Endocrine Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Endocrine Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Endocrine Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrine Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endocrine Testing Service industry.

Chapter 3: Detailed analysis of Endocrine Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Endocrine Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Endocrine Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Endocrine Testing Service Industry Trends Table 2. Endocrine Testing Service Industry Drivers Table 3. Endocrine Testing Service Industry Opportunities and Challenges Table 4. Endocrine Testing Service Industry Restraints Table 5. Global Endocrine Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Endocrine Testing Service Revenue Share by Company (2021-2026) Table 7. Global Endocrine Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Endocrine Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global Endocrine Testing Service Company, Product Type & Application Table 10. Global Endocrine Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Endocrine Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Prolactin Testing Table 15. Significant Companies of Progesterone Testing Table 16. Significant Companies of Testosterone Testing Table 17. Global Endocrine Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Endocrine Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Endocrine Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Endocrine Testing Service Sales Value Share by Type (2021-2026) Table 21. Global Endocrine Testing Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Clinics Table 24. Global Endocrine Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Endocrine Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Endocrine Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Endocrine Testing Service Sales Value Share by Application (2021-2026) Table 28. Global Endocrine Testing Service Sales Value Share by Application (2027-2032) Table 29. Global Endocrine Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Endocrine Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Endocrine Testing Service Sales Value Share by Region (2021-2026) Table 32. Global Endocrine Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Endocrine Testing Service Sales Value Share by Region (2027-2032) Table 34. Global Endocrine Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Endocrine Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Endocrine Testing Service Sales Value Market Share by Country (2021-2026) Table 37. Global Endocrine Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Endocrine Testing Service Sales Value Market Share by Country (2027-2032) Table 39. Hoffmann-La Roche Ltd. Company Information Table 40. Hoffmann-La Roche Ltd. Business Overview Table 41. Hoffmann-La Roche Ltd. Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Hoffmann-La Roche Ltd. Endocrine Testing Service Product Portfolio Table 43. Hoffmann-La Roche Ltd. Recent Development Table 44. Abbott Laboratories Company Information Table 45. Abbott Laboratories Business Overview Table 46. Abbott Laboratories Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Abbott Laboratories Endocrine Testing Service Product Portfolio Table 48. Abbott Laboratories Recent Development Table 49. Agilent Technologies Company Information Table 50. Agilent Technologies Business Overview Table 51. Agilent Technologies Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Agilent Technologies Endocrine Testing Service Product Portfolio Table 53. Agilent Technologies Recent Development Table 54. BioMerieux S.A. Company Information Table 55. BioMerieux S.A. Business Overview Table 56. BioMerieux S.A. Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. BioMerieux S.A. Endocrine Testing Service Product Portfolio Table 58. BioMerieux S.A. Recent Development Table 59. Bio-Rad Laboratories, Inc. Company Information Table 60. Bio-Rad Laboratories, Inc. Business Overview Table 61. Bio-Rad Laboratories, Inc. Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Bio-Rad Laboratories, Inc. Endocrine Testing Service Product Portfolio Table 63. Bio-Rad Laboratories, Inc. Recent Development Table 64. Siemens Healthineers Company Information Table 65. Siemens Healthineers Business Overview Table 66. Siemens Healthineers Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Siemens Healthineers Endocrine Testing Service Product Portfolio Table 68. Siemens Healthineers Recent Development Table 69. Danaher Corporation Company Information Table 70. Danaher Corporation Business Overview Table 71. Danaher Corporation Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Danaher Corporation Endocrine Testing Service Product Portfolio Table 73. Danaher Corporation Recent Development Table 74. DiaSorin S.p.A. Company Information Table 75. DiaSorin S.p.A. Business Overview Table 76. DiaSorin S.p.A. Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. DiaSorin S.p.A. Endocrine Testing Service Product Portfolio Table 78. DiaSorin S.p.A. Recent Development Table 79. Immunodiagnostic Systems Company Information Table 80. Immunodiagnostic Systems Business Overview Table 81. Immunodiagnostic Systems Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Immunodiagnostic Systems Endocrine Testing Service Product Portfolio Table 83. Immunodiagnostic Systems Recent Development Table 84. Laboratory Corporation of America Holdings Company Information Table 85. Laboratory Corporation of America Holdings Business Overview Table 86. Laboratory Corporation of America Holdings Endocrine Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Laboratory Corporation of America Holdings Endocrine Testing Service Product Portfolio Table 88. Laboratory Corporation of America Holdings Recent Development Table 89. Fujirebio, Inc. Company Information Table 90. Fujirebio, Inc. Business Overview Table 91. Fujirebio, Inc. Endocrine Testing Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Fujirebio, Inc. Endocrine Testing Service Product Portfolio Table 93. Fujirebio, Inc. Recent Development Table 94. Thermo Fisher Scientific Inc. Company Information Table 95. Thermo Fisher Scientific Inc. Business Overview Table 96. Thermo Fisher Scientific Inc. Endocrine Testing Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Thermo Fisher Scientific Inc. Endocrine Testing Service Product Portfolio Table 98. Thermo Fisher Scientific Inc. Recent Development Table 99. Quest Diagnostics Company Information Table 100. Quest Diagnostics Business Overview Table 101. Quest Diagnostics Endocrine Testing Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Quest Diagnostics Endocrine Testing Service Product Portfolio Table 103. Quest Diagnostics Recent Development Table 104. Sysmex Corporation Company Information Table 105. Sysmex Corporation Business Overview Table 106. Sysmex Corporation Endocrine Testing Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sysmex Corporation Endocrine Testing Service Product Portfolio Table 108. Sysmex Corporation Recent Development Table 109. MP Biomedicals Company Information Table 110. MP Biomedicals Business Overview Table 111. MP Biomedicals Endocrine Testing Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. MP Biomedicals Endocrine Testing Service Product Portfolio Table 113. MP Biomedicals Recent Development Table 114. Ortho Clinical Diagnostics Company Information Table 115. Ortho Clinical Diagnostics Business Overview Table 116. Ortho Clinical Diagnostics Endocrine Testing Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Ortho Clinical Diagnostics Endocrine Testing Service Product Portfolio Table 118. Ortho Clinical Diagnostics Recent Development Table 119. Meridian Life Science, Inc. Company Information Table 120. Meridian Life Science, Inc. Business Overview Table 121. Meridian Life Science, Inc. Endocrine Testing Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Meridian Life Science, Inc. Endocrine Testing Service Product Portfolio Table 123. Meridian Life Science, Inc. Recent Development Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Endocrine Testing Service Product Image Figure 2. Global Endocrine Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrine Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Endocrine Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Prolactin Testing Image Figure 8. Progesterone Testing Image Figure 9. Testosterone Testing Image Figure 10. Global Endocrine Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Endocrine Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Endocrine Testing Service Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Clinics Image Figure 15. Global Endocrine Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Endocrine Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Endocrine Testing Service Sales Value Share by Application (2021-2032) Figure 18. Global Endocrine Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Endocrine Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Endocrine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Endocrine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Endocrine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Endocrine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Endocrine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Endocrine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Endocrine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Endocrine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Endocrine Testing Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Endocrine Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Endocrine Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Prolactin Testing
  • Progesterone Testing
  • Testosterone Testing
Applications
  • Hospitals
  • Clinics
Companies covered
  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Agilent Technologies
  • BioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Immunodiagnostic Systems
  • Laboratory Corporation of America Holdings
  • Fujirebio, Inc.
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics
  • Sysmex Corporation
  • MP Biomedicals
  • Ortho Clinical Diagnostics
  • Meridian Life Science, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Endocrine Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Endocrine Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Endocrine Testing Service Market Dynamics
  1. 2.1 Endocrine Testing Service Industry Trends
  2. 2.2 Endocrine Testing Service Industry Drivers
  3. 2.3 Endocrine Testing Service Industry Opportunities and Challenges
  4. 2.4 Endocrine Testing Service Industry Restraints
3 Endocrine Testing Service Market by Company
  1. 3.1 Global Endocrine Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global Endocrine Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global Endocrine Testing Service Company Ranking (2024-2026)
  4. 3.4 Global Endocrine Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Endocrine Testing Service Company Product Type and Application
  6. 3.6 Global Endocrine Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Endocrine Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Endocrine Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Endocrine Testing Service Market by Type
  1. 4.1 Endocrine Testing Service Type Introduction
  2. 4.1.1 Prolactin Testing
  3. 4.1.2 Progesterone Testing
  4. 4.1.3 Testosterone Testing
  5. 4.2 Global Endocrine Testing Service Sales Value by Type
  6. 4.2.1 Global Endocrine Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Endocrine Testing Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Endocrine Testing Service Sales Value Share by Type (2021-2032)
5 Endocrine Testing Service Market by Application
  1. 5.1 Endocrine Testing Service Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Endocrine Testing Service Sales Value by Application
  5. 5.2.1 Global Endocrine Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Endocrine Testing Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Endocrine Testing Service Sales Value Share by Application (2021-2032)
6 Endocrine Testing Service Regional Value Analysis
  1. 6.1 Global Endocrine Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Endocrine Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Endocrine Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Endocrine Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Endocrine Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America Endocrine Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Endocrine Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Endocrine Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Endocrine Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Endocrine Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Endocrine Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America Endocrine Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Endocrine Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Endocrine Testing Service Sales Value Share by Country, 2025 VS 2032
7 Endocrine Testing Service Country-level Value Analysis
  1. 7.1 Global Endocrine Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Endocrine Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Endocrine Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Endocrine Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Endocrine Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Endocrine Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Endocrine Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hoffmann-La Roche Ltd.
  2. 8.1.1 Hoffmann-La Roche Ltd. Company Information
  3. 8.1.2 Hoffmann-La Roche Ltd. Business Overview
  4. 8.1.3 Hoffmann-La Roche Ltd. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hoffmann-La Roche Ltd. Endocrine Testing Service Product Portfolio
  6. 8.1.5 Hoffmann-La Roche Ltd. Recent Developments
  7. 8.2 Abbott Laboratories
  8. 8.2.1 Abbott Laboratories Company Information
  9. 8.2.2 Abbott Laboratories Business Overview
  10. 8.2.3 Abbott Laboratories Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Laboratories Endocrine Testing Service Product Portfolio
  12. 8.2.5 Abbott Laboratories Recent Developments
  13. 8.3 Agilent Technologies
  14. 8.3.1 Agilent Technologies Company Information
  15. 8.3.2 Agilent Technologies Business Overview
  16. 8.3.3 Agilent Technologies Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Agilent Technologies Endocrine Testing Service Product Portfolio
  18. 8.3.5 Agilent Technologies Recent Developments
  19. 8.4 BioMerieux S.A.
  20. 8.4.1 BioMerieux S.A. Company Information
  21. 8.4.2 BioMerieux S.A. Business Overview
  22. 8.4.3 BioMerieux S.A. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BioMerieux S.A. Endocrine Testing Service Product Portfolio
  24. 8.4.5 BioMerieux S.A. Recent Developments
  25. 8.5 Bio-Rad Laboratories, Inc.
  26. 8.5.1 Bio-Rad Laboratories, Inc. Company Information
  27. 8.5.2 Bio-Rad Laboratories, Inc. Business Overview
  28. 8.5.3 Bio-Rad Laboratories, Inc. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Rad Laboratories, Inc. Endocrine Testing Service Product Portfolio
  30. 8.5.5 Bio-Rad Laboratories, Inc. Recent Developments
  31. 8.6 Siemens Healthineers
  32. 8.6.1 Siemens Healthineers Company Information
  33. 8.6.2 Siemens Healthineers Business Overview
  34. 8.6.3 Siemens Healthineers Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Siemens Healthineers Endocrine Testing Service Product Portfolio
  36. 8.6.5 Siemens Healthineers Recent Developments
  37. 8.7 Danaher Corporation
  38. 8.7.1 Danaher Corporation Company Information
  39. 8.7.2 Danaher Corporation Business Overview
  40. 8.7.3 Danaher Corporation Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Danaher Corporation Endocrine Testing Service Product Portfolio
  42. 8.7.5 Danaher Corporation Recent Developments
  43. 8.8 DiaSorin S.p.A.
  44. 8.8.1 DiaSorin S.p.A. Company Information
  45. 8.8.2 DiaSorin S.p.A. Business Overview
  46. 8.8.3 DiaSorin S.p.A. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DiaSorin S.p.A. Endocrine Testing Service Product Portfolio
  48. 8.8.5 DiaSorin S.p.A. Recent Developments
  49. 8.9 Immunodiagnostic Systems
  50. 8.9.1 Immunodiagnostic Systems Company Information
  51. 8.9.2 Immunodiagnostic Systems Business Overview
  52. 8.9.3 Immunodiagnostic Systems Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Immunodiagnostic Systems Endocrine Testing Service Product Portfolio
  54. 8.9.5 Immunodiagnostic Systems Recent Developments
  55. 8.10 Laboratory Corporation of America Holdings
  56. 8.10.1 Laboratory Corporation of America Holdings Company Information
  57. 8.10.2 Laboratory Corporation of America Holdings Business Overview
  58. 8.10.3 Laboratory Corporation of America Holdings Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Laboratory Corporation of America Holdings Endocrine Testing Service Product Portfolio
  60. 8.10.5 Laboratory Corporation of America Holdings Recent Developments
  61. 8.11 Fujirebio, Inc.
  62. 8.11.1 Fujirebio, Inc. Company Information
  63. 8.11.2 Fujirebio, Inc. Business Overview
  64. 8.11.3 Fujirebio, Inc. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fujirebio, Inc. Endocrine Testing Service Product Portfolio
  66. 8.11.5 Fujirebio, Inc. Recent Developments
  67. 8.12 Thermo Fisher Scientific Inc.
  68. 8.12.1 Thermo Fisher Scientific Inc. Company Information
  69. 8.12.2 Thermo Fisher Scientific Inc. Business Overview
  70. 8.12.3 Thermo Fisher Scientific Inc. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Thermo Fisher Scientific Inc. Endocrine Testing Service Product Portfolio
  72. 8.12.5 Thermo Fisher Scientific Inc. Recent Developments
  73. 8.13 Quest Diagnostics
  74. 8.13.1 Quest Diagnostics Company Information
  75. 8.13.2 Quest Diagnostics Business Overview
  76. 8.13.3 Quest Diagnostics Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Quest Diagnostics Endocrine Testing Service Product Portfolio
  78. 8.13.5 Quest Diagnostics Recent Developments
  79. 8.14 Sysmex Corporation
  80. 8.14.1 Sysmex Corporation Company Information
  81. 8.14.2 Sysmex Corporation Business Overview
  82. 8.14.3 Sysmex Corporation Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sysmex Corporation Endocrine Testing Service Product Portfolio
  84. 8.14.5 Sysmex Corporation Recent Developments
  85. 8.15 MP Biomedicals
  86. 8.15.1 MP Biomedicals Company Information
  87. 8.15.2 MP Biomedicals Business Overview
  88. 8.15.3 MP Biomedicals Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 MP Biomedicals Endocrine Testing Service Product Portfolio
  90. 8.15.5 MP Biomedicals Recent Developments
  91. 8.16 Ortho Clinical Diagnostics
  92. 8.16.1 Ortho Clinical Diagnostics Company Information
  93. 8.16.2 Ortho Clinical Diagnostics Business Overview
  94. 8.16.3 Ortho Clinical Diagnostics Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Ortho Clinical Diagnostics Endocrine Testing Service Product Portfolio
  96. 8.16.5 Ortho Clinical Diagnostics Recent Developments
  97. 8.17 Meridian Life Science, Inc.
  98. 8.17.1 Meridian Life Science, Inc. Company Information
  99. 8.17.2 Meridian Life Science, Inc. Business Overview
  100. 8.17.3 Meridian Life Science, Inc. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Meridian Life Science, Inc. Endocrine Testing Service Product Portfolio
  102. 8.17.5 Meridian Life Science, Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst